SecSonar.com

Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Kazia Therapeutics Limited (KZIA) is a Biotechnology company based in AU with a market capitalization of $20.8M. Revenue declined 98.2% year-over-year and free cash flow was negative at -$9.2M. This page tracks KZIA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

AU · 9 employees · IPO Jan 6, 1999

Valuation

Valuation & price

$13.16 · as of May 17, 2026 · -16.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$15.72$10.36$5.00Jul 25Dec 25Jul 26Jul 7, 25$6.55Jul 9, 25$9.53Jul 11, 25$10.80Jul 15, 25$10.80Jul 17, 25$10.27Jul 21, 25$8.97Jul 23, 25$10.28Jul 25, 25$9.82Jul 29, 25$8.62Jul 31, 25$8.38Aug 4, 25$8.34Aug 6, 25$8.67Aug 11, 25$8.17Aug 13, 25$8.33Aug 15, 25$8.04Aug 19, 25$7.30Aug 21, 25$7.30Aug 25, 25$7.50Aug 27, 25$7.81Aug 29, 25$8.07Sep 3, 25$8.03Sep 5, 25$7.76Sep 9, 25$8.05Sep 11, 25$8.15Sep 16, 25$8.01Sep 18, 25$7.73Sep 22, 25$7.52Sep 24, 25$7.88Sep 26, 25$7.33Sep 30, 25$7.21Oct 2, 25$6.31Oct 6, 25$6.78Oct 8, 25$7.16Oct 10, 25$6.98Oct 14, 25$6.98Oct 16, 25$6.99Oct 21, 25$7.03Oct 23, 25$6.74Oct 27, 25$7.30Oct 29, 25$7.69Oct 31, 25$7.81Nov 4, 25$7.66Nov 6, 25$7.50Nov 10, 25$7.39Nov 12, 25$7.60Nov 14, 25$6.27Nov 18, 25$5.76Nov 20, 25$7.48Nov 25, 25$12.79Nov 28, 25$10.55Dec 2, 25$10.06Dec 4, 25$13.38Dec 8, 25$15.72Dec 10, 25$12.80Dec 12, 25$10.43Dec 16, 25$9.99Dec 18, 25$9.98Dec 22, 25$10.00Dec 24, 25$8.00Dec 29, 25$6.18Jan 2, 26$5.00Jan 6, 26$6.56Jan 8, 26$6.78Jan 12, 26$6.44Jan 14, 26$6.84Jan 16, 26$7.16Jan 21, 26$7.08Jan 23, 26$7.51Jan 27, 26$7.15Jan 29, 26$6.10Feb 2, 26$6.20Feb 4, 26$6.00Feb 9, 26$5.72Feb 11, 26$5.26Feb 13, 26$5.01Feb 18, 26$5.79Feb 20, 26$6.14Feb 24, 26$6.54Feb 26, 26$8.85Mar 2, 26$8.83Mar 4, 26$8.78Mar 6, 26$8.25Mar 10, 26$8.52Mar 12, 26$8.01Mar 17, 26$7.53Mar 19, 26$7.91Mar 23, 26$7.12Mar 25, 26$7.30Mar 27, 26$7.16Mar 31, 26$7.44Apr 2, 26$7.34Apr 7, 26$9.62Apr 9, 26$9.10Apr 13, 26$8.99Apr 15, 26$10.00Apr 17, 26$11.10Apr 22, 26$11.53Apr 24, 26$12.26Apr 28, 26$11.85Apr 30, 26$13.64May 4, 26$12.84May 6, 26$13.84May 8, 26$14.44May 12, 26$14.30May 14, 26$13.83May 18, 26$12.56May 20, 26$12.97May 22, 26$13.66May 28, 26$12.67Jun 1, 26$12.56Jun 3, 26$10.95Jun 5, 26$10.99Jun 9, 26$11.42Jun 11, 26$12.54Jun 15, 26$14.08Jun 17, 26$14.25Jun 22, 26$14.00Jun 24, 26$14.63Jun 26, 26$14.22Jul 2, 26$13.25
$5.0052-week range$15.72
Loading valuation history…

Fundamentals

Key fundamentals

$20.8M

Market cap

-98.2%

Revenue growth (YoY)

100.0%

Gross margin

-$9.2M

Free cash flow (USD)

-$3.9M

Net debt

Net cash position

128.4%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$4.1MFY 2017$8.8MFY 2018$13.1KFY 2019$1.6KFY 2020$988.1KFY 2021$15.2MFY 2022$10.0KFY 2023$555.00FY 2024$2.3MFY 2025$42.0K
$4.1M$42K

Free cash flow by year

2016 → 2025

FY 2016$-12.5MFY 2017$-11.4MFY 2018$-8.7MFY 2019$-6.7MFY 2020$-8.8MFY 2021$-9.1MFY 2022$-22.8MFY 2023$-15.2MFY 2024$-9.6MFY 2025$-13.3M
-$12.5M-$13.3M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: —

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingEmployment AgreementJun 2, 2026Filing
  • 6-K filingClinical Trial ExpansionMay 26, 2026Filing
  • 6-K filingInvestor PresentationApr 27, 2026Filing
  • 6-K filingEmployment AgreementApr 15, 2026Filing
  • 6-K filingOncology Platform ExpansionApr 13, 2026Filing

Questions

Frequently asked questions

What is Kazia Therapeutics Limited's market cap?

Kazia Therapeutics Limited (KZIA) has a market capitalization of $20.8M.

What is KZIA's P/E ratio?

A meaningful P/E ratio is not available for KZIA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying KZIA stock?

SEC Form 4 filings show no open-market insider buys at Kazia Therapeutics Limited in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

PLUR

Pluri Inc.

$20.7M

VTGN

VistaGen Therapeutics, Inc.

$20.9M

ABVC

ABVC BioPharma, Inc.

$20.3M

XCUR

Exicure, Inc.

$20.1M

SER

Serina Therapeutics, Inc.

$20M

DARE

Daré Bioscience, Inc.

$21.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.